Formulation comprising GLP-1
The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the pres...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
23.07.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention. |
---|---|
AbstractList | The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention. |
Author | KHAN MOHAMMED AMIN JONES BRYAN EDWARD MCGILL JOHN MCNEILL |
Author_xml | – fullname: MCGILL JOHN MCNEILL – fullname: JONES BRYAN EDWARD – fullname: KHAN MOHAMMED AMIN |
BookMark | eNrjYmDJy89L5WSQccsvyi3NSSzJzM9TSM7PLSjKLM7MS1dw9wnQNeRhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGhwRYmlkbGxgZORsZEKAEAEhUk2Q |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US8492330B2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US8492330B23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:57:36 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US8492330B23 |
Notes | Application Number: US201113004964 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130723&DB=EPODOC&CC=US&NR=8492330B2 |
ParticipantIDs | epo_espacenet_US8492330B2 |
PublicationCentury | 2000 |
PublicationDate | 20130723 |
PublicationDateYYYYMMDD | 2013-07-23 |
PublicationDate_xml | – month: 07 year: 2013 text: 20130723 day: 23 |
PublicationDecade | 2010 |
PublicationYear | 2013 |
RelatedCompanies | EMISPHERE TECHNOLOGIES, INC KHAN MOHAMMED AMIN JONES BRYAN EDWARD MCGILL JOHN MCNEILL |
RelatedCompanies_xml | – name: KHAN MOHAMMED AMIN – name: JONES BRYAN EDWARD – name: MCGILL JOHN MCNEILL – name: EMISPHERE TECHNOLOGIES, INC |
Score | 2.903344 |
Snippet | The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Formulation comprising GLP-1 |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130723&DB=EPODOC&locale=&CC=US&NR=8492330B2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKepNp-J0Sg_SWzA2bVMPRWjaOsRtxa2y20hDCrvM4Sr--76EbnrRW0jg5QPeZ957P4Dbh5pqpStO6spEq2o_IJJpTgKDbRFQH3WgqXcejcNh6T_Pg3kHlttaGNsn9Ms2R0SOUsjvjZXX658gVmpzKzd31RKn3h_zWZy6rXeMApl7zE2TOCsm6US4QsTl1B2_xpFpRMZogtJ6D61obrK_srfEFKWsf2uU_Bj2CyS2ak6go1c9OBRb4LUeHIza_24ctqy3OYVBjtZli7XlmERw5E5UO87TS0Huz8DJs5kYEtxmsbvSopzuDsTOoYuevr4ARxt_0ZhsUqPXRJVUIZMq4jVlMvQi2of-n2Qu_1m7giPPojhw4rEBdJuPT32NurSpbuwrfAMeUXcm |
link.rule.ids | 230,309,783,888,25578,76884 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2K1ag6S2-KazctDEPIyapIGm0hvJQkb6KUtNuLfd3ZJqxe9Lbsw-4B57sx8ALcPDeU1ryzSVCJa1egGKRm3iCGwLQyqow4U9c5JakaF_jIzZj1YbGthZJ_QL9kcETmqRn5vpbxe_wSxfJlbubmrFji1egxzx1c77xgFsqUx1XedIJv4E0_1PKeYqumbY4tGZIy6KK330MK2RZv94N0VRSnr3xolPIL9DIkt22Po8eUQBt4WeG0IB0n3343DjvU2JzAO0brssLYUkQiO3IlqR3mKM3J_CkoY5F5EcJv57krzYro7EDuDPnr6_BwULvxFYbKVHL0mWpe1ycrathrKSlOz6QhGf5K5-GftBgZRnsTz-Dl9vYRDTSI6WERjY-i3H5_8CvVqW13LF_kG28Z6Fg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Formulation+comprising+GLP-1&rft.inventor=MCGILL+JOHN+MCNEILL&rft.inventor=JONES+BRYAN+EDWARD&rft.inventor=KHAN+MOHAMMED+AMIN&rft.date=2013-07-23&rft.externalDBID=B2&rft.externalDocID=US8492330B2 |